VOYA Investment Management
BCYC

VOYA Investment Management’s Bicycle Therapeutics BCYC Stock Holding History

VOYA Investment Management’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-48,420
Closed -$678K – 2646
2024
Q4 		$678K Sell
48,420
-56,870
-54% -$1.22M ﹤0.01% 1799
2024
Q3 		$2.38M Sell
105,290
-19,330
-16% -$446K ﹤0.01% 1281
2024
Q2 		$2.52M Sell
124,620
-12,155
-9% -$275K ﹤0.01% 1245
2024
Q1 		$3.41M Buy
136,775
+23,625
+21% +$502K ﹤0.01% 1138
2023
Q4 		$2.05M Sell
113,150
-205
-0.2% -$3.39K ﹤0.01% 1356
2023
Q3 		$2.28M Buy
113,355
+24,985
+28% +$571K ﹤0.01% 1281
2023
Q2 		$2.26M Buy
88,370
+7,775
+10% +$181K ﹤0.01% 1308
2023
Q1 		$1.71M Buy
80,595
+14,555
+22% +$365K ﹤0.01% 1417
2022
Q4 		$1.95M Sell
66,040
-1,707
-3% -$45.8K ﹤0.01% 1336
2022
Q3 		$1.58M Buy
+67,747
New +$1.61M ﹤0.01% 1424

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

VOYA Investment Management's BCYC Position: Q1 2025 in Review

VOYA Investment Management sold out of Bicycle Therapeutics (BCYC) in Q1 2025, closing a stake of 48,420 shares — an estimated $678K sold.

VOYA Investment Management first reported a position in BCYC in Q3 2022 and held it in 10 quarters. The position peaked at $3.41M in Q1 2024. 95 funds tracked by Wall St. Rank hold BCYC as of Q1 2025.

  • VOYA Investment Management reported no remaining Bicycle Therapeutics position as of Q1 2025 after selling out during the quarter.
  • VOYA Investment Management sold 48,420 Bicycle Therapeutics shares in Q1 2025, an estimated $678K.
  • VOYA Investment Management first reported a position in Bicycle Therapeutics in Q3 2022 and held it in 10 quarters.
  • VOYA Investment Management's Bicycle Therapeutics position peaked at $3.41M in Q1 2024.
  • 95 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2025.

Based on VOYA Investment Management's 13F filing for Q1 2025, filed 15 May 2025.